The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Also ….
“I won again and look forward to meeting and overcoming the next challenge”.
Does this perhaps mean that he has achieved what he wanted from a CAR-T deal to progress as he sees fit and now wants the same for CBR?
LOL
Trift x
The third party testing has also been done before on the first 3 PQ runs so should be a doddle.
Also we have Prevail on board where we did not for the first runs and submission so we should be pretty confident that things will go smoothly from here on in.
All the best to LTH’s.
Trift x
Hi Tilly,
It has been a long long wait but I share your and others’ sentiments and sense a pivotal sea-change for Hemo and patients and shareholders.
Patience will prevail and pay off substantially.
GLA
LOL
Trift x
From the transcript:
“We also achieved global group of concept for CBR administration for brain tumors….”
“…..In summary we have a noble proprietory technology we achieved through performance and it’s directly applicable to U.S. Department of Defence…….”
and from Prevail. “…….We’re a committed investor and anybody who would like to join us as an investor…….”
……..Errrrrr yes please Prevail but I already have and at a vast discount to your investment.
The door is still open, just.
LOL
Trift x